4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-043123
Chief Business Development Off sold 417 shares at $40.00 ($16,680)
- Chief Business Development Off acquired 417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-07-20 | Option exercise | +417 | $6.27 | $2,615 | 417 | D |
| BENZENO SHARON Chief Business Development Off | 2020-07-20 | Sale | −417 | $40.00 | $16,680 | 0 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Business Development Off | 2020-07-20 | Option exercise · Stock Option (Right to Buy) | −417 | 3,750 | D | ||
| Open-market sales · 417 sh · avg $40.00 · $16,680 | |||||||
Loading xslF345X03/doc4.xml…